SCHEMBL3675655

SCHEMBL3675655

CCCOC(=O)c1ccc(C=O)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.66
TSHR P16473 4/20 0.66
ESR1 P03372 2/20 0.66
TDP1 Q9NUW8 2/20 0.66
CHRM1 P11229 1/20 0.66
SLC6A2 P23975 1/20 0.66
KDR P35968 1/20 0.66
LMNA P02545 4/20 0.62
MAPT P10636 5/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
RAB9A P51151 3/20 0.58
NPC1 O15118 2/20 0.58
STAT1 P42224 1/20 0.58
STS P08842 1/20 0.54
CYP1A2 P05177 2/20 0.53
CYP2C19 P33261 2/20 0.53
CYP2D6 P10635 2/20 0.53
MAPK1 P28482 1/20 0.53
NR1H2 P55055 1/20 0.53
RNASEL Q05823 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9099239 0.90 ESR1 (0.68) ALDH1A1TSHRESR1TDP1CHRM1
SCHEMBL19219007 0.89 ALDH1A1 (0.62) ALDH1A1TSHRESR1TDP1CHRM1
SCHEMBL9097123 0.88 ALDH1A1 (0.65) ALDH1A1TSHRESR1LMNAMAPT
SCHEMBL11860535 0.87 ALDH1A1 (0.68) ALDH1A1TSHRESR1TDP1CHRM1
SCHEMBL11860527 0.87 ALDH1A1 (0.68) ALDH1A1TSHRESR1TDP1CHRM1
SCHEMBL9762364 0.87 ALDH1A1 (0.68) ALDH1A1TSHRESR1LMNAMAPT
SCHEMBL3041650 0.87 ALDH1A1 (0.68) ALDH1A1TSHRESR1LMNAMAPT
SCHEMBL3906362 0.87 ALDH1A1 (0.68) ALDH1A1TSHRESR1LMNAMAPT
SCHEMBL7721712 0.87 ALDH1A1 (0.68) ALDH1A1TSHRESR1LMNAMAPT
SCHEMBL49950 0.87 ALDH1A1 (0.84) ALDH1A1TSHRESR1TDP1CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025096655-A1 SYSTEMS AND METHODS FOR MANUFACTURING ELECTROCHROMICS KENNESAW STATE UNIVERSITY RESEARCH AND SERVICE FOUNDATION, INC. (US) 2025-05-08 WO disclosed
US-20250135444-A1 SYSTEMS AND METHODS FOR MANUFACTURING ELECTROCHROMICS KENNESAW STATE UNIVERSITY RESEARCH AND SERVICE FOUNDATION, INC. 2025-05-01 US disclosed
CN-113348188-B Phenolic hydroxyl group-containing resin, photosensitive composition, resist film, curable composition, and cured product DIC株式会社 2024-05-10 CN disclosed
CN-113227181-B Resist composition DIC株式会社 2023-07-18 CN disclosed
CN-116023607-A Phenolic hydroxyl group-containing resin DIC株式会社 2023-04-28 CN disclosed
CN-113348188-A Phenolic hydroxyl group-containing resin, photosensitive composition, resist film, curable composition, and cured product DIC株式会社 2021-09-03 CN disclosed
CN-113227181-A Resist composition DIC株式会社 2021-08-06 CN disclosed
US-8541477-B2 Methods of depolymerizing terephthalate polyesters INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2013-09-24 US disclosed
US-20120223270-A1 METHODS OF DEPOLYMERIZING TEREPHTHALATE POLYESTERS KING ABDULAZIZ CITY FOR SCIENCE AND TECHNOLOGY (SA) 2012-09-06 US disclosed
US-20100168046-A1 METHODS OF USING [3.2.0] HETEROCYCLIC COMPOUNDS AND ANALOGS THEREOF FOR TREATING INFECTIOUS DISEASES NEREUS PHARMACEUTICALS, INC. (US) 2010-07-01 US disclosed
EP-0180897-B1 5-FLUOROURACIL DERIVATIVES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-08-07 EP disclosed
EP-0436902-A1 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-07-17 EP disclosed
EP-0431891-A1 Epoxy compounds, production processes thereof and cured product of the epoxy compound TEIJIN LIMITED (JP) 1991-06-12 EP disclosed
US-4983609-A Anticancer agents OTSUKA PHARMACEUTICAL (JP) 1991-01-08 US disclosed
US-4864021-A ANTICARCINOGENIC AGENTS, ANTITUMOR AGENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-09-05 US disclosed
EP-0323441-A2 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-07-05 EP disclosed
US-4785010-A AGING RESISTANCE OF HUMANS CASSELLA AKTIENGESELLSCHAFT (DE) 1988-11-15 US disclosed
EP-0124067-B1 2-(AMINOALKYL)-PYRROLE DERIVATIVES, PROCESS FOR THEIR MANUFACTURE AND THEIR USE CASSELLA Aktiengesellschaft (DE) 1986-12-17 EP disclosed
EP-0180188-A2 A composition for increasing the anti-cancer activity of an anti-cancer compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-07 EP disclosed
EP-0124067-A1 2-(Aminoalkyl)-pyrrole derivatives, process for their manufacture and their use CASSELLA Aktiengesellschaft (DE) 1984-11-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250135444-A1 SYSTEMS AND METHODS FOR MANUFACTURING ELECTROCHROMICS DHPS, HMBS, NDUFS6 ALDH1A1 514/4885TSHR 4717/4885ESR1 3474/4885
US-20120223270-A1 METHODS OF DEPOLYMERIZING TEREPHTHALATE POLYESTERS DDT, TRHDE, TERT ALDH1A1 2617/4885TSHR 1355/4885ESR1 3395/4885
US-20100168046-A1 METHODS OF USING [3.2.0] HETEROCYCLIC COMPOUNDS AND ANALOGS THEREOF FOR TREATING INFECTIOUS DISEASES GOT2, CYP11B2, CYP27A1 ALDH1A1 350/4885TSHR 2479/4885ESR1 4019/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.